Position in LLY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$6,070,927,443
+$1,161,496,869 QoQ
Shares Held
5,061,510
-5.2% QoQ
Ownership
0.538%
of shares outstanding
% of Portfolio
1.47%
of 13F equity value
Holder Rank
#27
of 4,632 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Nuveen, LLC holds $17,178,530,722 across 15 Drug Manufacturers - General names. LLY ranks #1 (35.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
5,061,510 | $6,070,927,443 | |
| 2 | JNJ |
Johnson & Johnson
|
12,978,519 | $3,296,154,468 | |
| 3 | ABBV |
AbbVie Inc.
|
9,509,991 | $2,393,094,134 | |
| 4 | AZN |
Astrazeneca PLC
|
7,183,115 | $1,362,062,264 | |
| 5 | MRK |
Merck & Co., Inc.
|
9,662,399 | $1,241,618,271 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
8,336,930 | $1,053,287,734 | |
| 7 | AMGN |
Amgen Inc
|
2,345,865 | $849,484,633 | |
| 8 | PFE |
Pfizer Inc
|
14,445,787 | $347,854,549 |
All Filings in LLY
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,070,927,443 | 5,061,510 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $4,909,430,574 | 5,337,672 | Shares | Defined | 2026-04-30 | |
| 2025-12-31 | $5,840,426,380 | 5,434,572 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $4,133,000,088 | 5,416,776 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $4,435,317,564 | 5,689,733 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $4,613,912,351 | 5,586,459 | Shares | Defined | 2025-05-12 | |
| No filing history on record for this holder in this stock. | ||||||